Myrexis (MYRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MYRX Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Myrexis adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2013)
(Mar 31 2013) (Dec 31 2012) (Sep 30 2012) (Jun 30 2012)
Assets
Cash & cash equivalent1.14
Marketable Securities, Current SH0.08
Cash & Short-term Investments1.00
Disposal Group, Including Discontinued Operation, Inventory, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.03
Total Current Assets1.24
Equipment/Property/Plant Net0.00
Long-term investments0.00
Other Assets, Noncurrent0.00
Total Assets1.24
Liabilities
Accounts Payable, Current AC0.00
Accrued Liabilities, Current AC0.07
Total Current Liabilities0.07
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.07
Stockholders' Equity
Common Stock Value0.35
Additional Paid In Capital Common Stock129.31
Retained Earnings / Accumulated Deficit-128.49
Other Equity0.00
Common Stockholder's Equity1.16
Total Stockholder's Equity1.16
Liabilities & Stockholder's Equity1.24
4 historic quarters locked

Sign in to unlock the full Myrexis balance sheet history.

About MYRX Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.